PursueCare, a company that provides personalized virtual addiction treatment, announced the re-release of FDA-cleared RESET and RESET-O, prescription digital therapeutics (PDTs) for substance use disorder and opioid use disorder, respectively.
RESET and RESET-O were initially developed and commercialized by Pear Therapeutics, which filed for Chapter 11 bankruptcy last year. PursueCare acquired...
Oshi Health, a digital gastrointestinal health company, announced it scored $60 million in Series C funding in a round led by Oak HC/FT.
The round also included existing investors CVS Health Ventures, Flare Capital Partners, Takeda Digital Ventures, Bessemer Venture Partners and First Cressey Ventures.
WHAT IT DOES
Oshi Health provides patients with gastrointestinal issues with virtual access...
Alchemy, a company that helps develop and scale in-house pharmacy programs focused on HIV and Hepatitis C (HCV) patient populations, announced it closed $31 million in seed financing led by Andreessen Horowitz ("a16z") Bio + Health.
Professional basketball player turned investor Earvin "Magic" Johnson participated in the round alongside Sandberg Bernthal Venture Partners, Banc of California and...
Glooko, the maker of a digital platform for managing diabetes and other chronic diseases, has secured $100 million in Series F funding and announced Mike Alvarez as the company's newly appointed CEO.
Georgian led the round with participation from Canaan, Health Catalyst Capital, and other investors and business partners.
Alvarez formerly held the CEO role at Qardio, a remote patient monitoring...
ASX-listed Echo IQ has obtained regulatory approval in the United States for its AI-driven solution that supports structural heart disease diagnosis.
WHAT IT'S ABOUT
Two years since coming to the US, the company has now received 510(k) clearance from the Food and Drug Administration for EchoSolv AS, which is specifically indicated to support the diagnosis of severe aortic stenosis (a form of...
New York-based mental health technology company Resilience Lab has acquired online psychiatric medication management platform Options MD, which will allow Resilience to offer integrated prescription management and psychotherapy services for moderate to severe mental illness.
Resilience Lab is an online mental healthcare platform that connects patients with therapists who specialize in depression...
Amwell, a digital care company that connects providers, payers and patients, announced that Hello Heart, a company focused on cardiac health management, has become a partner in its clinical programs portfolio accessible on the Amwell Converge platform.
The alliance allows Amwell health plan clients to give their employer accounts access to Hello Health cardiovascular's platform. The platform...
Medtronic, which develops, manufactures and sells medical therapy devices, has issued a voluntary recall of its MiniMed 600 series or 700 series insulin pumps due to the pump's potentially shortened battery life.
The company issued a field action, starting on July 31, notifying customers globally that they should monitor their MiniMed pump's built-in alarms and alerts to keep track of battery...
Mental health app Lissun bags $3M for AI integration
Mental health platform Lissun in India has scored $2.5 million in a pre-Series A funding round led by RPSG Capital Ventures.
With its fresh funds, the startup plans to integrate AI into its suite of digital mental health solutions which target corporates, schools, and families of children with neurodevelopmental conditions. The new funds will...
Rippl, a company focused on providing mental health solutions to seniors with dementia and other cognitive conditions, announced it closed a $23 million Series A funding round.
Tina Hoang-To, Kin Ventures' founding general partner, led the round, with participation from the company's seed investors General Catalyst, ARCH Ventures, GV (Google Ventures), Mass General Brigham Ventures, F-Prime and...
